written on 28.04.2014
Tags:
,

BioNotebook: Hyperion/Andromeda lead deal makers; Theravance tops public company fundraising

TAGS: ,

Hyperion buying Andromeda; Zogenix sells Sumavel to Endo; Hydra/Boehringer collaborate; Medivation, OncoFusion partner; Theravance, Alimera raise debt; Sarepta, Agios sell stock; and Radius, Alder, Aldeyra set IPO terms.

Latest Report